<DOC>
	<DOCNO>NCT01230762</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety dapoxetine men rapid ejaculation .</brief_summary>
	<brief_title>An Open-Label Study Long-Term Safety Dapoxetine HCl Treatment Rapid Ejaculation</brief_title>
	<detailed_description>This multicenter , open-label ( patient Investigators know name drug receive ) study evaluate long-term safety efficacy dapoxetine therapy adult men premature ( rapid ) ejaculation ( PE ) participate 1 2 previous study dapoxetine ( ALZA Protocol C-2002-012 C-2002-013 ) . The length study 9 month . During study , patient monitor safety review adverse event finding routine laboratory test , vital sign measurement , electrocardiogram ( ECGs ) , physical examination . Oral tablet dapoxetine ( 30 mg 60 mg ) self-administered patient daily , need , 9 month . No 1 dose within 24-hour period take . If 60 mg dose dapoxetine well tolerate , dose may decrease 30 mg dapoxetine remainder study . Patients tolerate 30 mg dose dapoxetine discontinue study .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>Enrollment within 30 day completion 1 2 Phase 3 control study ( ALZA Study C2002012 Study C2002013 ) In opinion Investigator , patient could safely continue use dapoxetine treatment Had systolic blood pressure &lt; =180 mm Hg diastolic blood pressure &lt; =100 mm Hg Agreement patient 's sexual partner ( childbearing potential ) ensure use medically acceptable method contraception duration study Currently take protocoldefined prohibited medication Reported diagnosis sexually transmitted disease , Had new allergy hypersensitivity dapoxetine selective serotonin reuptake inhibitor In opinion Investigator incapable follow study schedule reason</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Dapoxetine , Orgasmic disorder</keyword>
	<keyword>Premature ejaculation</keyword>
	<keyword>Sexual dysfunction</keyword>
	<keyword>Sexual intercourse</keyword>
	<keyword>Ejaculation</keyword>
	<keyword>Erectile Dysfunction</keyword>
</DOC>